TargetMol

AN-019

Product Code:
 
TAR-T26625
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26625-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26625-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26625-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AN-019, a Bcr-Abl kinase inhibitor, is used potentially for the treatment of chronic myeloid leukemia.
CAS:
879507-25-2
Formula:
C25H17F6N5O
Molecular Weight:
517.435
Purity:
0.98
SMILES:
Cc1ccc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1Nc1nccc(n1)-c1cccnc1

References

1. Gondi CS, Gorantla B, Bhujanga Rao AK, Amala K, Naidu MU, Jogi KV, Venkat Ramana G, Myneni PC, Junnarkar A, Rao JS. Antitumor activity of NRC-AN-019 in a pre-clinical breast cancer model. Int J Oncol. 2011 Sep;39(3):641-8. doi: 10.3892/ijo.2011.1079. PubMed PMID: 21674127. 2. Amala K, Bhujanga Rao AK, Gorantla B, Gondi CS, Rao JS. Design, synthesis and preclinical evaluation of NRC-AN-019. Int J Oncol. 2013 Jan;42(1):168-78. doi: 10.3892/ijo.2012.1697. PubMed PMID: 23151973.